Abstract
Background and Objectives: This study aimed to investigate the relationships among pulmonary function, dyspnea, clinical frailty, and cognitive performance during post-COVID follow-up and to examine their relationships within a hypothesized serial pathway. Materials and Methods: This retrospective cross-sectional study included 226 adults evaluated in a post-COVID follow-up program. Pulmonary function, modified Medical Research Council (mMRC) dyspnea scores, Clinical Frailty Scale (CFS) scores, and Mini-Mental State Examination (MMSE) scores were assessed. A path model (FEV1 → mMRC → CFS → MMSE), including an additional direct path from FEV1 to CFS and adjusted for age, sex, and BMI, was evaluated using robust maximum-likelihood (MLR) estimation. Indirect effects were assessed using 5000 bootstrap resamples. FVC- and PEF-based models were examined as sensitivity analyses. Results: The primary path analysis included 213 participants with complete data, and the hypothesized model showed acceptable fit (Yuan–Bentler χ2(2) = 5.57, p = 0.062; robust CFI = 0.990; robust RMSEA = 0.089; SRMR = 0.017). Lower FEV1 was associated with higher mMRC scores (β = −0.470), higher mMRC scores with higher CFS scores (β = 0.373), and higher CFS scores with lower MMSE scores (β = −0.538; all p < 0.001). The direct path from FEV1 to CFS was also significant (β = −0.310; p < 0.001). The serial indirect effect through mMRC and CFS was significant (β = 0.094; 95% CI: 0.043–0.149), as was the total indirect effect (β = 0.261; 95% CI: 0.124–0.411). The FVC-based sensitivity analysis showed a similar pattern, with a significant total indirect effect (β = 0.245; 95% CI: 0.118–0.387) and good model fit. Conclusions: The findings suggest that pulmonary function, dyspnea, clinical frailty, and cognitive performance are interrelated during post-COVID follow-up. These associations warrant further investigation to determine their potential clinical relevance. Given the cross-sectional design, the observed pathways should not be interpreted as evidence of causal mediation.
Keywords:
COVID-19; pulmonary function; dyspnea; clinical frailty; cognitive function; path analysis